Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes is a research paper published in Molecular Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21 EY031108
National Institutes of Health
Grant: R01 EY032238
Office of Research Infrastructure Programs
Grant: P510D011107
University of California
Grant: EY034123
University of California
Grant: U24 EY029904
University of California
Grant: EY033733
National Eye Institute
Grant: P30 EY12576
Foundation Fighting Blindness Inc
Grant: R01 EY029298
Foundation Fighting Blindness Inc
Grant: R01 EY030431
NEI NIH HHS
Grant: R01 EY033733
University of California, Davis
California National Primate Research Center
BrightFocus Foundation
U.S. Department of Agriculture
FWCI
1.09
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals